Suppr超能文献

微波消融与胸腔镜手术治疗多原发性肺癌的回顾性研究:倾向评分匹配分析

A retrospective study of microwave ablation and thoracoscopic surgery for multiple primary lung cancer: a propensity score matching analysis.

作者信息

Li Bangsheng, Gao Shengguai, Mao Jie, Yang Zhenghong, Chen Ying, Wang Xi, Huang Yunchao

机构信息

Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.

Department of Thoracic Tumor Center, Northeast Yunnan Central Hospital, Zhaotong, Yunnan, China.

出版信息

Front Surg. 2025 Mar 11;12:1547048. doi: 10.3389/fsurg.2025.1547048. eCollection 2025.

Abstract

PURPOSE

Microwave ablation (MWA) is a minimally invasive local treatment with demonstrated safety and efficacy, but its role in managing multiple primary lung cancer (MPLC) is not well-established. This study retrospectively evaluates the clinical effectiveness of MWA compared to video-assisted thoracoscopic surgery (VATS) in treating MPLC.

MATERIALS AND METHODS

A retrospective analysis was conducted using data from patients with non-small cell lung cancer (NSCLC) treated at Peking University Cancer Hospital Yunnan Hospital between January 2021 and April 2024. All patients had undergone surgical resection for their first primary lung cancer (FPLC) and subsequently received either MWA or VATS for second primary lung cancer (SPLC). After 1:1 propensity score matching (PSM), 202 patients per group were included. Study endpoints included progression-free survival (PFS), overall survival (OS), complications, and pulmonary function changes.

RESULTS

Median follow-up was 24.47 months. Survival analysis revealed a statistically significant difference in PFS between MWA and VATS groups (HR = 2.74, 95% CI: 1.40-5.36,  = 0.006), while OS showed no difference (HR = 1.41, 95% CI: 0.45-4.36,  = 0.56). The incidence of grade ≥ II complications was significantly lower in the MWA group ( < 0.001). Pulmonary function tests indicated no significant changes in forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1%, maximal voluntary ventilation (MVV), and diffusion capacity of the lung for carbon monoxide%(DLCO%) before and 1-3 month post MWA ( > 0.05).

CONCLUSIONS

In MPLC patients with stage IA SPLC, VATS demonstrates a greater clinical efficacy advantage in terms of local tumor control compared to MWA. Additionally, MWA provided significant advantages in reducing complication severity and preserving pulmonary function. These findings suggest that the therapeutic approach combining surgery with MWA represents a safe and effective option for MPLC.

摘要

目的

微波消融(MWA)是一种具有已证实的安全性和有效性的微创局部治疗方法,但其在治疗多原发性肺癌(MPLC)中的作用尚未明确确立。本研究回顾性评估了MWA与电视辅助胸腔镜手术(VATS)相比在治疗MPLC中的临床效果。

材料与方法

使用2021年1月至2024年4月在北京大学肿瘤医院云南医院接受治疗的非小细胞肺癌(NSCLC)患者的数据进行回顾性分析。所有患者均已对其第一原发性肺癌(FPLC)进行了手术切除,随后对第二原发性肺癌(SPLC)接受了MWA或VATS治疗。经过1:1倾向评分匹配(PSM)后,每组纳入202例患者。研究终点包括无进展生存期(PFS)、总生存期(OS)、并发症以及肺功能变化。

结果

中位随访时间为24.47个月。生存分析显示,MWA组和VATS组之间的PFS存在统计学显著差异(HR = 2.74,95% CI:1.40 - 5.36,P = 0.006),而OS无差异(HR = 1.41,95% CI:0.45 - 4.36,P = 0.56)。MWA组中≥II级并发症的发生率显著更低(P < 0.001)。肺功能测试表明,在MWA前及MWA后1 - 3个月,用力肺活量(FVC)、第1秒用力呼气量(FEV1)、FEV1%、最大自主通气量(MVV)和肺一氧化碳弥散量%(DLCO%)均无显著变化(P > 0.05)。

结论

在IA期SPLC的MPLC患者中,与MWA相比,VATS在局部肿瘤控制方面显示出更大的临床疗效优势。此外,MWA在降低并发症严重程度和保留肺功能方面具有显著优势。这些发现表明,手术联合MWA的治疗方法是MPLC的一种安全有效的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971e/11933129/bbb37a91c6d2/fsurg-12-1547048-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验